Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding

Welsh immunodeficient patients on immunoglobulin replacement therapy (IgRT) who were considered high risk for severe coronavirus disease 2019 (COVID-19) were directed to shield. Consequently, patients receiving hospital-based intravenous immunoglobulin (IVIg) quickly transitioned to home-based self-...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Clare, Jolles, Stephen, Ponsford, Mark J., Evans, Kimberly, Carne, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
PRIMARY IMMUNE DEFICIENCY DISEASE: Edited by M. Teresa de la Morena and Stephen Jolles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612677/
https://www.ncbi.nlm.nih.gov/pubmed/36165464
http://dx.doi.org/10.1097/ACI.0000000000000864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612677/
https://www.ncbi.nlm.nih.gov/pubmed/36165464
http://dx.doi.org/10.1097/ACI.0000000000000864

Ejemplares similares